TOCILIZUMAB

tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes

TOCILIZUMAB (13685G)

tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes
13685G
Body System:
Manner of administration:Injection
General Schedule
Authority Required (STREAMLINED)

Restriction  14499

Indication: Severe active rheumatoid arthritis
Treatment phase: Subsequent continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 4 # of repeats: 5 DPMQ: $801.70 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Actemra Subcutaneous Injection